We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:7311S
GW Pharmaceuticals PLC
02 December 2003
For Immediate Release 2 December 2003
GW Pharmaceuticals plc
("GW" or "the Company")
Re: Share Price Movement
GW notes recent speculation relating to the UK regulatory submission for its
Sativex product.
As GW and Bayer announced at the time of the recent extension of their marketing
agreement, the assessment by the Medicines and Healthcare products Regulatory
Authority ("MHRA") continues to proceed according to the normal regulatory
process.
There is no material new information to disclose in relation to the Company's
application to the MHRA. The normal regulatory process is ongoing and the
precise timing for completion of the assessment remains at the discretion of the
MHRA.
- Ends -
Enquiries:
Weber Shandwick Square Mile
Kevin Smith 020 7067 0700
This information is provided by RNS
The company news service from the London Stock Exchange
END
SPMDGMGZLZKGFZG
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
